Clinical features and complications of liver cirrhosis in a high-altitude population (Huancayo, 3,250 m a.s.l.)
DOI:
https://doi.org/10.24265/horizmed.2020.v20n2.08Keywords:
Liver cirrhosis, Ascites, Hepatic encephalopathy, Hepatorenal syndromeAbstract
Objective: Liver cirrhosis is responsible for significant morbidity and mortality. This research aims to determine the clinical presentation, etiology and complications of patients with liver cirrhosis from a population living at a high altitude region in Peru. Materials and methods: A retrospective study of the clinical presentation and complications of liver cirrhosis was conducted. One hundred eight (108) medical records of patients with liver cirrhosis admitted to the Internal Medicine Service of the Hospital Nacional Ramiro Prialé Prialé, Huancayo,were evaluated between 2010 and 2012. Results: Patients’ mean age was 60.5 years (range: 12–82 years) and 62.9 % were males. The most common etiology was alcohol consumption (63 %), followed by chronic hepatitis B and C (7.4 % and 2.8 %, respectively). Fifty-eight point three percent (58.3 %) of the patients had a Child-Pugh class B score and 31.30 % of them had a Child-Pugh class C score. The most frequent clinical presentation was abdominal distension (87 %). The most common complications were ascites (56 %), hepatic encephalopathy (47.2 %) and hepatorenal syndrome (8.3 %). Conclusions: Alcoholic liver cirrhosis was the most common etiology. The most frequent complications were ascites and hepatic encephalopathy.
Downloads
References
Campollo O, Valencia-Salinas JJ, Berumen-Arellano A, PérezAranda MA, Panduro-Cerda A, Segura-Ortega J. Características epidemiológicas de la cirrosis hepática en el Hospital Civil de Guadalajara. Salud Pública Mex. 1997; 39(3): 195-200.
Medina E, Kaempffer A. Cirrosis hepática en Chile. Rev Chil Salud Pública. 2002; 6 (1): 3.
Farfán G, Cabezas C. Mortalidad por enfermedades digestivas y hepatobiliares en el Perú, 1995-2000. Rev Gastroenterol Perú. 2002; 22(4): 212-33.
Biblioteca Virtual en Salud. Análisis de la Situación de Salud Junín-2006. Oficina de Epidemiología de la DIRESA Junín [internet]. 2018. Disponible en: http://www.bvsde.paho.org/documentosdigitales/bvsde/texcom/asisregiones/ Junin/Junin2006.pdf
Dávalos Moscol M. Epidemiología de la cirrosis hepática en el Perú. Red Peruana de Bibliotecas en Salud. 2003; 6(2): 26-7.
Hamad N, Travis S. Gastrointestinal function. In: Swenson E, Bärtsch P, eds. High Altitude: Springer: New York; 2014.
Lumbreras L, León-Velarde F. El medio ambiente en Los Andes. En: Monge C, León-Velarde F, eds. El reto fisiológico de vivir en Los Andes. Lima: IFEA-UPCH; 2003. pp. 29-38.
Bustíos C, Dávalos M, Román, R, Zumaeta E. Características epidemiológicas y clínicas de la cirrosis hepática en la Unidad de Hígado del HNERM EsSalud. Rev Gastroenterol Perú. 2007; 27(3): 238-45.
Lebroc PD, Reina AB, Camacho AJ, Massíp RM. Caracterización clínica de pacientes con cirrosis hepática en el Hospital Provincial Docente “Dr. Antonio Luaces Iraola”. Mediciego. 2011; 17(2): 1-8.
Rodríguez-Magallán A, Valencia-Romero HS, Trinidad-Altamirano J. Etiología y complicaciones de la cirrosis hepática en el Hospital Juárez de México. Rev Hosp Jua Mex. 2008; 75(4): 247-56.
Beltrán-Jara A, Neciosup-Puican E. Factores de riesgo para cirrosis hepática en la población adulta de la Red Asistencial EsSalud Lambayeque. Rev Cuerpo Méd HNAAA. 2011; 4(2): 77-83.
Equipo de Redacción Perú 21. Consumo de alcohol aumenta entre las adolescentes peruanas. [internet]. 2016. Disponible en: https://peru21.pe/lima/consumo-alcohol-aumenta-adolescentesperuanas-236759./
Ruiz E, Almonte M, Pizarro R, Celis J, Montalbeti JA, Urbano R. Infección con virus de la Hepatitis B y Hepatitis C como factores de riesgo para hepatocarcinoma en el Perú: estudio de casos y controles. Rev Gastroenterol Perú. 1998; 18(3): 199-212.
Ginés P, Arroyo V. Cirrosis hepática. En: Farreras-Rozman, ed. Medicina interna. 17ma ed. Elsevier: Barcelona; 2014. pp. 250-3.
Mathurin SA, Agüero AP, Dascani NA, Prestera JA, Gianserra C, Londero E, et al. Anemia en pacientes internados con cirrosis: prevalencia, significación clínica y factores predictivos. Acta Gastroenterol Latinoam. 2009; 39(2): 103-11.
González-Casas R, Jones EA, Moreno-Otero R. Spectrum of anemia associated with chronic liver disease. World J Gastroenterol. 2009; 15(37): 4653-8.
Hurtado A, Escudero E, Pando J, Sharma S, Johnson RJ. Cardiovascular and renal effects of chronic exposure to high altitude. Nephrol Dial Transplant. 2012; 27(4): 11-6.
Moeller M, Thonig A, Pohl S, Ripoll C, Zipprich A. Hepatic arterial vasodilation is independent of portal hypertension in early stages of cirrhosis. PLoS One. 2015; 10(3): e0121229.
Sepehrinezhad A, Dehghanian A, Rafati A, Ketabchi F. Impact of liver damage on blood-borne variables and pulmonary hemodynamic responses to hypoxia and hyperoxia in anesthetized rats. BMC Cardiovasc Disord. 2020; 20(1): 13.
Voiosu AM, Voiosu TA, Smarandache B, Radoi A, Mateescu RB, Baicus CR, et al. The impact of hypoxaemia on the outcome in liver cirrhosis. J Gastrointestin Liver Dis. 2016; 25(4): 481-7.
Berendsohn S. Hepatic function at high altitudes. Arch Intern Med. 1962; 109: 56-64.
Jurgens G, Christense HR, Brosen K, Sonne J, Loft S, Olven NV. Acute hypoxia and cytochrome p450-mediated hepatic drug metabolism in humans. Clin Pharmacol Ther. 2002; 71(4): 214-20.
Streit M, Goggelmann C, Dehnert C, Burhenne J, Riedel K, Menold E, et al. Cytochrome P450 enzyme-mediated drug metabolism at exposure to acute hypoxia (corresponding to an altitude of 4500m). Eur J Clin Pharmacol. 2005; 6(1): 39-46.
Kalson NS, Hext F, Davies AJ, Chan CW, Wright AD, Imray CH, et al. Do changes in gastro-intestinal blood flow explain hight-altitude anorexia?. Eur J Clin Invest. 2010; 40(8): 735-41.
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Horizonte Médico (Lima)

This work is licensed under a Creative Commons Attribution 4.0 International License.
Horizonte Médico (Lima) (Horiz. Med.) journal’s research outputs are published free of charge and are freely available to download under the open access model, aimed at disseminating works and experiences developed in biomedical and public health areas, both nationally and internationally, and promoting research in the different fields of human medicine. All manuscripts accepted and published in the journal are distributed free of charge under the terms of a Creative Commons license – Attribution 4.0 International (CC BY 4.0).